The rush to create a vaccine for Lyme led to mismanagement; a chronic relapsing seronegative disease does not fit the vaccine model. (Pfizer is in phase 3 clinical trials) Read my article in the BMJ: https://www.bmj.com/content/369/bmj.m1041/rr-1